Table of Contents
What changed
Reported revenue — which for this listed investment vehicle reflects portfolio gains/losses rather than operating turnover — swung from NZD (58.5)m to NZD 27.6m, an NZD 86.1m reversal. NPAT moved in parallel from NZD (60.4)m to NZD 23.6m, an NZD 84.0m swing. Prior-year PBT was NZD (61.2)m; the current-year PBT line is not separately disclosed in the extraction. Operating cash flow, closing cash, total liabilities and total equity for FY23 are also absent from the supplied data, and the total-assets figure of NZD 0.03m against a prior NZD 180.3m appears to be an extraction artefact rather than a genuine balance-sheet collapse.
What matters
- Return of positive mark-to-market: the NZD 86.1m revenue swing is essentially a reversal of the FY22 drawdown. For an investment vehicle, this is the headline and is inherently market-driven, not operational.
- Second-half did all the work: HY23 revenue was NZD (9.4)m and HY23 NPAT was NZD (11.6)m, implying second-half revenue of roughly NZD 37.0m and second-half NPAT of roughly NZD 35.2m. The full-year positive result is entirely a 2H phenomenon.
- Disclosure gaps: with no FY23 figure for operating cash flow, cash balance, equity, or the declared dividend in the extraction, the read on capital-allocation continuity (prior DPS was 1.85c) and on NTA-backed value is incomplete.
Expectations
No stated targets or guidance were provided. For a listed investment company, the relevant shape context is the portfolio return profile rather than forward work. On that basis, the HY23-to-FY23 progression shows the result was built almost entirely in the second half; the run-rate implication is not meaningful because these are mark-to-market gains, not a recurring revenue stream. The release, as extracted, does not support any inference about FY24 portfolio positioning or distribution policy.
Quality of result
The headline recovery is real but not durable in the operating sense: it is the arithmetic reversal of prior-year mark-downs on a portfolio. Prior-year operating cash flow of NZD 3.4m was already an order of magnitude below reported profit, underlining that for this vehicle NPAT and cash generation move on different drivers (dividend income plus realisations versus unrealised revaluations). Without the FY23 cash-flow statement, it is not possible to confirm whether cash distributions from investees held up, which is the line most relevant to dividend capacity. Tax visibility is also limited: prior-year effective rate was ~1.3% on a loss, and the current-period tax line is not broken out, so NPAT is used here as the cleaner reported measure only because PBT is unavailable.
Unresolved
- What was FY23 operating cash flow, and did it grow from the NZD 3.4m prior-year base?
- What is the FY23 closing cash, total equity and NTA per share, and how does NTA compare with the traded price?
- Was a final dividend declared, and does full-period DPS match or differ from the prior 1.85c?
- How much of the NZD 27.6m revenue line is realised versus unrealised, and what is the concentration of the portfolio driving the 2H recovery?
- Why does the extracted total-assets figure appear so divergent from prior — is this a reporting structure change or an extraction error?
This briefing cannot assess FY23 cash generation, balance-sheet strength, dividend continuity or portfolio composition, because those disclosures are not present in the supplied extraction.
Key metrics
| Metric | FY23 | FY22 | Change |
|---|---|---|---|
| Revenue | $27.6m | −$58.5m | +147.3% ↑ |
| Net profit after tax | $23.6m | −$60.4m | +139.1% ↑ |
| Net cash inflow from operating activities | — | $3.4m | — |
| Declared dividend per share | — | 1.9c | — |
| Total assets | $0.03m | $180.3m | -100.0% ↓ |
Analytical metrics
| Metric | FY23 | FY22 | Context |
|---|---|---|---|
| HY23 share of FY23 revenue | -34.0% | — | Other half was 134.0% |
| HY23 share of FY23 NPAT | -49.0% | — | Other half was 149.0% |
| Profit from continuing operations | $23.6m | −$60.4m | +$84m |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.
Source-backed analysis from the filing set attached to this briefing.